Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Inflammatory Breast Neoplasms × Letrozole × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 52 Neoplasms 6 Endometrial Neoplasms 5 Ovarian Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 3 Advanced Breast Cancer 3 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Neoplasms by Site 2 Neoplasm Metastasis 2 Hereditary Sensory and Autonomic Neuropathies 2 Breast Neoplasms, Male 2 Breast Diseases 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1 Leiomyoma 1 Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 HR+/HER2- Breast Cancer 1 Fallopian Tube Neoplasms 1 Cystadenocarcinoma, Serous 1

Interventions

Paclitaxel 4 Doxorubicin 3 Cyclophosphamide 3 pertuzumab 2 pembrolizumab 2 Trastuzumab 2 Specimen Handling 2 Radiotherapy 2 trastuzumab biosimilar HLX02 1 ruxolitinib 1 onvansertib 1 olaparib 1 neratinib 1 X-Rays 1 Therapeutics 1 Taxes 1 Tamoxifen 1 Surgical Procedures, Operative 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Palliative Care 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Methods 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Injections, Subcutaneous 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡